These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

175 related articles for article (PubMed ID: 17336778)

  • 1. Drug-induced myoclonus: a French pharmacovigilance database study.
    Brefel-Courbon C; Gardette V; Ory F; Montastruc JL
    Neurophysiol Clin; 2006; 36(5-6):333-6. PubMed ID: 17336778
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Adverse drug reactions in patients older than 70 years during the heat wave occurred in France in summer 2003: A study from the French PharmacoVigilance Database.
    Michenot F; Sommet A; Bagheri H; Lapeyre-Mestre M; Montastruc JL;
    Pharmacoepidemiol Drug Saf; 2006 Oct; 15(10):735-40. PubMed ID: 16924603
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Drug related falls: a study in the French Pharmacovigilance database.
    Souchet E; Lapeyre-Mestre M; Montastruc JL
    Pharmacoepidemiol Drug Saf; 2005 Jan; 14(1):11-6. PubMed ID: 15508129
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Overview of adverse reactions to nefopam: an analysis of the French Pharmacovigilance database.
    Durrieu G; Olivier P; Bagheri H; Montastruc JL;
    Fundam Clin Pharmacol; 2007 Oct; 21(5):555-8. PubMed ID: 17868209
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Drug-induced hiccup: a review of the France pharmacologic vigilance database].
    Bagheri H; Cismondo S; Montastruc JL
    Therapie; 1999; 54(1):35-9. PubMed ID: 10216420
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Adverse effects of voriconazole: analysis of the French Pharmacovigilance Database.
    Eiden C; Peyrière H; Cociglio M; Djezzar S; Hansel S; Blayac JP; Hillaire-Buys D;
    Ann Pharmacother; 2007 May; 41(5):755-63. PubMed ID: 17456542
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Drug-induced dementia: a case/non-case study in the French Pharmacovigilance database].
    Favrelière S; Lafay-Chebassier C; Alkhidir F; Merlet I; Pérault Pochat MC
    Therapie; 2007; 62(6):507-11. PubMed ID: 18316017
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Confusion, a rather serious adverse drug reaction with valproic acid: a review of the French Pharmacovigilance database.
    Bondon-Guitton E; Sommet A; Montastruc JL;
    Pharmacopsychiatry; 2009 Mar; 42(2):61-5. PubMed ID: 19308880
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A comparative study of adverse drug reactions during two heat waves that occurred in France in 2003 and 2006.
    Sommet A; Durrieu G; Lapeyre-Mestre M; Montastruc JL;
    Pharmacoepidemiol Drug Saf; 2012 Mar; 21(3):285-8. PubMed ID: 22162094
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The nature of the scientific evidence leading to drug withdrawals for pharmacovigilance reasons in France.
    Olivier P; Montastruc JL
    Pharmacoepidemiol Drug Saf; 2006 Nov; 15(11):808-12. PubMed ID: 16700082
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [French pharmacovigilance database system: examples of utilisation].
    Moore N; Noblet C; Kreft-Jais C; Lagier G; Ollagnier M; Imbs JL
    Therapie; 1995; 50(6):557-62. PubMed ID: 8745956
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Use of the capture-recapture method to assess the frequency of "serious" adverse drug reactions: experience of Toulouse University Hospital].
    Montastruc JL; Lugardon S; Desboeuf K; Fernet P; Lapeyre-Mestre M
    Bull Acad Natl Med; 2008 Feb; 192(2):421-30; discussion 430-1. PubMed ID: 18819693
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Drug-induced hyperglycemia: a study in the French pharmacovigilance database].
    Chebane L; Tavassoli N; Bagheri H; Montastruc JL;
    Therapie; 2010; 65(5):447-58. PubMed ID: 21144480
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Diplopia, blepharoptosis, and ophthalmoplegia and 3-hydroxy-3-methyl-glutaryl-CoA reductase inhibitor use.
    Fraunfelder FW; Richards AB
    Ophthalmology; 2008 Dec; 115(12):2282-5. PubMed ID: 18930555
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Applying quantitative methods for detecting new drug safety signals in pharmacovigilance national database.
    Shalviri G; Mohammad K; Majdzadeh R; Gholami K
    Pharmacoepidemiol Drug Saf; 2007 Oct; 16(10):1136-40. PubMed ID: 17705214
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Diplopia and fluoroquinolones.
    Fraunfelder FW; Fraunfelder FT
    Ophthalmology; 2009 Sep; 116(9):1814-7. PubMed ID: 19643481
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Pediatric drug surveillance and the Food and Drug Administration's adverse event reporting system: an overview of reports, 2003-2007.
    Johann-Liang R; Wyeth J; Chen M; Cope JU
    Pharmacoepidemiol Drug Saf; 2009 Jan; 18(1):24-7. PubMed ID: 19009550
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Anxiolytics, hypnotics, and antidepressants dispensed to adolescents in a French region in 2002.
    Mancini J; Thirion X; Masut A; Saillard C; Pradel V; Romain F; Pastor MJ; Coudert C; Micallef J
    Pharmacoepidemiol Drug Saf; 2006 Jul; 15(7):494-503. PubMed ID: 16700077
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Drugs and dilated cardiomyopathies: A case/noncase study in the French PharmacoVigilance Database.
    Montastruc G; Favreliere S; Sommet A; Pathak A; Lapeyre-Mestre M; Perault-Pochat MC; Montastruc JL;
    Br J Clin Pharmacol; 2010 Mar; 69(3):287-94. PubMed ID: 20233200
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Drug-induced parkinsonian syndromes: a 10-year experience at a regional center of pharmaco-vigilance].
    Llau ME; Nguyen L; Senard JM; Rascol O; Montastruc JL
    Rev Neurol (Paris); 1994 Nov; 150(11):757-62. PubMed ID: 7597368
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.